August 3, 2025 - 09:28

TSMC has big plans for the US, and one of the more important ones is producing the cutting-edge N2 technology in the country. The semiconductor giant is reportedly gearing up to shift its advanced 2nm technology to its facilities in Arizona, marking a significant step in its expansion strategy. This move comes despite previous tensions with the Taiwan government, which has expressed concerns over the potential impact on the local semiconductor industry.
By establishing new production lines in Arizona, TSMC aims to enhance its manufacturing capabilities and cater to the growing demand for advanced chips in the American market. The decision reflects a broader trend of semiconductor companies seeking to diversify their production bases and reduce reliance on Taiwan amid geopolitical uncertainties.
The introduction of 2nm technology is expected to revolutionize various sectors, including artificial intelligence, automotive, and consumer electronics, by enabling faster and more efficient chips. As TSMC embarks on this ambitious project, the implications for both the US and global semiconductor landscape could be profound.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...